Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 known ✓ | P27487 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | ALB | P02768 | 1/20 | 0.60 |
| ▸ | ADA | P00813 | 1/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | PI4KA | P42356 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.52 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.52 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | ADCY1 | Q08828 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL8630949 | 1.00 | MAPK1 (0.60) | MAPK1ALDH1A1LMNAALBADA | |
| Phosphoric Acid SCHEMBL4966781 | 1.00 | MAPK1 (0.60) | MAPK1ALDH1A1LMNAALBADA | |
| SCHEMBL6915651 | 0.96 | MAPK1 (0.58) | MAPK1ALDH1A1LMNAALBADA | |
| SCHEMBL8094890 | 0.94 | ADA (0.65) | MAPK1ALDH1A1LMNAALBADA | |
| SCHEMBL10381269 | 0.94 | ADA (0.65) | MAPK1ALDH1A1LMNAALBADA | |
| SCHEMBL9197787 | 0.94 | ADA (0.65) | MAPK1ALDH1A1LMNAALBADA | |
| SCHEMBL1374909 | 0.94 | ADA (0.65) | MAPK1ALDH1A1LMNAALBADA | |
| SCHEMBL29609293 | 0.94 | ADA (0.65) | MAPK1ALDH1A1LMNAALBADA | |
| SCHEMBL3541 | 0.94 | ADA (0.65) | MAPK1ALDH1A1LMNAALBADA | |
| SCHEMBL20419221 | 0.94 | ADA (0.65) | MAPK1ALDH1A1LMNAALBADA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 483 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025042729-A1 | CELL PREPARATION COMPOSITION, SYSTEM AND METHOD FOR SINGLE CELL TRANSCRIPTOMICS | Life Technologies Corporation (US) | 2025-02-27 | — | — | WO | claimed |
| EP-4479406-A1 | OXAZINE DYES AND THEIR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS | Promega Corporation (US) | 2024-12-25 | — | — | EP | claimed |
| US-20240287502-A1 | OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2024-08-29 | — | — | US | claimed |
| US-20240102003-A1 | OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2024-03-28 | — | — | US | claimed |
| US-20230278968-A1 | OXAZINE DYES AND THEIR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS | PROMEGA CORPORATION | 2023-09-07 | — | — | US | claimed |
| WO-2023159042-A1 | OXAZINE DYES AND THEIR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS | PROMEGA CORPORATION (US) | 2023-08-24 | — | — | WO | claimed |
| US-11485997-B2 | Nucleic acid sequence identification using solid-phase cyclic single base extension | INSILIXA, INC. (US) | 2022-11-01 | — | — | US | claimed |
| EP-3986907-A1 | OLIGONUCLEOTIDE-TETHERED TRIPHOSPHATE NUCLEOTIDES USEFUL FOR LABELLING NUCLEIC ACIDS FOR PREPARING NEXT-GENERATION SEQUENCING LIBRARIES | Thermo Fisher Scientific Baltics UAB (LT) | 2022-04-27 | — | — | EP | claimed |
| WO-2020257797-A1 | OLIGONUCLEOTIDE-TETHERED TRIPHOSPHATE NUCLEOTIDES USEFUL FOR LABELLING NUCLEIC ACIDS FOR PREPARING NEXT-GENERATION SEQUENCING LIBRARIES | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2020-12-24 | — | — | WO | claimed |
| US-20200399633-A1 | OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2020-12-24 | — | — | US | claimed |
| WO-1995008647-A1 | METHOD FOR CONSTRUCTION OF NORMALIZED cDNA LIBRARIES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1995-03-30 | — | — | WO | claimed |
| US-5366860-A | Spectrally resolvable rhodamine dyes for nucleic acid sequence determination | APPLIED BIOSYSTEMS, INC. (US) | 1994-11-22 | — | — | US | claimed |
| WO-1994016101-A2 | DNA SEQUENCING BY MASS SPECTROMETRY | KOESTER HUBERT (US) | 1994-07-21 | — | — | WO | claimed |
| EP-0496749-A4 | SPECTRALLY RESOLVABLE RHODAMINE DYES FOR NUCLEIC ACID SEQUENCE DETERMINATION | — | 1993-06-16 | — | — | EP | claimed |
| WO-1993011227-A1 | RECOMBINANT POLY(A) POLYMERASE | UNITED STATES BIOCHEMICAL CORPORATION (US) | 1993-06-10 | — | — | WO | claimed |
| EP-0496749-A1 | SPECTRALLY RESOLVABLE RHODAMINE DYES FOR NUCLEIC ACID SEQUENCE DETERMINATION. | APPLIED BIOSYSTEMS (US) | 1992-08-05 | — | — | EP | claimed |
| EP-0286418-B1 | ANTI-RETROVIRAL AGENTS AND DELIVERY SYSTEMS FOR THE SAME | US COMMERCE (US) | 1992-07-08 | — | — | EP | claimed |
| WO-1991005060-A2 | SPECTRALLY RESOLVABLE RHODAMINE DYES FOR NUCLEIC ACID SEQUENCE DETERMINATION | APPLIED BIOSYSTEMS, INC. (US) | 1991-04-18 | — | — | WO | claimed |
| WO-1988007854-A1 | NEW ANTI-RETROVIRAL AGENTS AND DELIVERY SYSTEM | UNITED STATES OF AMERICA, REPRESENTED BY THE UNITE (US) | 1988-10-20 | — | — | WO | claimed |
| EP-0286418-A1 | Anti-retroviral agents and delivery systems for the same | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1988-10-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230278968-A1 | OXAZINE DYES AND THEIR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS | POLRMT, POLB, POLN | DPP4 1850/4885MAPK1 4410/4885ALDH1A1 602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.